World Vaccine Congress Europe 2026 will take place from October 19 to 21, 2026, at RAI Amsterdam Convention Centre in Amsterdam, Netherlands. Organised by Terrapinn, the event focuses on vaccine research, development, clinical programmes, manufacturing and commercialisation. The first day is dedicated to pre-congress workshops, followed by two days of conference sessions and exhibition activity. More than 2,000 attendees, 280 speakers and over 150 exhibitors are expected to participate in the 2026 edition.
The exhibition brings together pharmaceutical and biotechnology companies, contract research and manufacturing organisations, laboratory service providers, technology suppliers and other businesses supporting vaccine development and production. Subjects represented across the event include pre-clinical development, immune profiling, clinical trials, vaccine delivery, formulation, bioprocessing and manufacturing, supply and logistics, emerging infectious diseases, antimicrobial resistance and therapeutic vaccines. BioPharma showcases and technology presentations also cover developments in vaccine platforms and production processes.
The conference programme examines scientific, manufacturing and policy issues across the vaccine lifecycle. Topics include cancer and therapeutic vaccines, respiratory diseases, bacterial vaccines, pandemic preparedness, veterinary vaccines, global health, platform technologies and vaccine access. Start-up presentations, scientific posters, working groups and one-to-one partnering meetings form additional parts of the programme. By bringing research organisations, manufacturers, government representatives and technology providers into the same event, the congress covers both scientific development and the industrial processes required to move vaccines from early research toward commercial production and distribution.
